Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Feb;65(2):161-9.
doi: 10.1007/s00262-015-1782-5. Epub 2016 Jan 4.

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

Affiliations

Toward harmonized phenotyping of human myeloid-derived suppressor cells by flow cytometry: results from an interim study

Susanna Mandruzzato et al. Cancer Immunol Immunother. 2016 Feb.

Abstract

There is an increasing interest for monitoring circulating myeloid-derived suppressor cells (MDSCs) in cancer patients, but there are also divergences in their phenotypic definition. To overcome this obstacle, the Cancer Immunoguiding Program under the umbrella of the Association of Cancer Immunotherapy is coordinating a proficiency panel program that aims at harmonizing MDSC phenotyping. After a consultation period, a two-stage approach was designed to harmonize MDSC phenotype. In the first step, an international consortium of 23 laboratories immunophenotyped 10 putative MDSC subsets on pretested, peripheral blood mononuclear cells of healthy donors to assess the level of concordance and define robust marker combinations for the identification of circulating MDSCs. At this stage, no mandatory requirements to standardize reagents or protocols were introduced. Data analysis revealed a small intra-laboratory, but very high inter-laboratory variance for all MDSC subsets, especially for the granulocytic subsets. In particular, the use of a dead-cell marker altered significantly the reported percentage of granulocytic MDSCs, confirming that these cells are especially sensitive to cryopreservation and/or thawing. Importantly, the gating strategy was heterogeneous and associated with high inter-center variance. Overall, our results document the high variability in MDSC phenotyping in the multicenter setting if no harmonization/standardization measures are applied. Although the observed variability depended on a number of identified parameters, the main parameter associated with variation was the gating strategy. Based on these findings, we propose further efforts to harmonize marker combinations and gating parameters to identify strategies for a robust enumeration of MDSC subsets.

Keywords: Flow cytometry; Myeloid-derived suppressor cells; Phenotyping; Proficiency panel.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Exemplary gating strategy included in the panel’s guideline. The figure shows the gating strategy proposed in the guidelines and made of three sequential steps, allowing the identification of the 10 putative MDSC subsets. Step 1 consists in doublets exclusion followed by dead-cell exclusion. Step 2 allows the identification of three MDSC subsets (MDSC1-2-8), and from a consecutive gate, the other seven defined MDSC populations are identified in step 3
Fig. 2
Fig. 2
Analysis of the impact of a dead-cell marker on MDSC quantification. Black bars indicate average %CV from analyses performed without exclusion of dead cells, while white bars refer to analyses considering only live cells (n = 18 evaluable laboratories reporting data for the 8-color panel). Intra-laboratory variance is shown in panel a, while panel b reports inter-laboratory variance. c Average %CV (n = 14 evaluable laboratories reporting data for the 8-color panel) of the frequencies of the ten MDSC subsets without normalization (black bar) and normalized on the number of singlets (yellow bar), lymphocytes (blue bar) and lymphocytes + monocytes (red bar)
Fig. 3
Fig. 3
Values of a representative subsets of monocytic (MDSC4 – panel a), granulocytic (MDSC5 – panel b) and immature (MDSC10 – panel c) MDSCs are shown as examples. Frequencies were normalized on the count of lymphocytes + monocytes for each laboratory performing either one 8-color panel or three 4-color panels for MDSC identification; the two paired histograms refer to the two independent experimental runs performed by each laboratory (black bars = first run, gray bars = second run). Missing values, not reported by single laboratories, were labeled with “m
Fig. 4
Fig. 4
a Average frequencies (n = 18 evaluable laboratories reporting data for the 8-color panel) of MDSC subsets normalized on lymphocytes + monocytes ( n%) identified either excluding or not the dead cells. Wilcoxon matched-pair test (***P < 0.001, ****P < 0.0001). b Average %CV (n = 18 evaluable laboratories reporting data for the 8-color panel) of the frequencies of MDSC subsets identified either using a homogenous gating strategy (white bar) or not (black bars)

References

    1. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol. 2012;12(4):253–268. doi: 10.1038/nri3175. - DOI - PMC - PubMed
    1. Huang A, Zhang B, Wang B, Zhang F, Fan KX, Guo YJ. Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients. Cancer Immunol Immunother. 2013;62(9):1439–1451. doi: 10.1007/s00262-013-1450-6. - DOI - PMC - PubMed
    1. Solito S, Falisi E, Diaz-Montero CM, Doni A, Pinton L, Rosato A, Francescato S, Basso G, Zanovello P, Onicescu G, Garrett-Mayer E, Montero AJ, Bronte V, Mandruzzato S. A human promyelocytic- like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood. 2011;118(8):2254–2265. doi: 10.1182/blood-2010-12-325753. - DOI - PMC - PubMed
    1. Walter S, Weinschenk T, Stenzl A, Zdrojowy R, Pluzanska A, Szczylik C, Staehler M, Brugger W, Dietrich PY, Mendrzyk R, Hilf N, Schoor O, Fritsche J, Mahr A, Maurer D, Vass V, Trautwein C, Lewandrowski P, Flohr C, Pohla H, Stanczak JJ, Bronte V, Mandruzzato S, Biedermann T, Pawelec G, Derhovanessian E, Yamagishi H, Miki T, Hongo F, Takaha N, Hirakawa K, Tanaka H, Stevanovic S, Frisch J, Mayer-Mokler A, Kirner A, Rammensee HG, Reinhardt C, Singh-Jasuja H. Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival. Nat Med. 2012;18(8):1254–1261. doi: 10.1038/nm.2883. - DOI - PubMed
    1. Wang L, Chang EW, Wong SC, Ong SM, Chong DQ, Ling KL. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol. 2013;190(2):794–804. doi: 10.4049/jimmunol.1202088. - DOI - PubMed

Publication types